Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2008